Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-02-13
2009-02-17
Jiang, Shaojia Anna (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S025000
Reexamination Certificate
active
07491805
ABSTRACT:
This invention features conjugates, degradable linkers, compositions, methods of synthesis, and applications thereof, including galactosamine and N-acetyl galactosamine derived conjugates of biologically active compounds, including antibodies, antivirals, chemotherapeutics, peptides, proteins, hormones, nucleosides, nucleotides, non-nucleosides, and nucleic acids including enzymatic nucleic acids, DNAzymes, allozymes, antisense, dsRNA, siNA, siRNA, triplex oligonucleotides, 2,5-A chimeras, decoys and aptamers.
REFERENCES:
patent: 4987071 (1991-01-01), Cech et al.
patent: 5108921 (1992-04-01), Low et al.
patent: 5334711 (1994-08-01), Sproat
patent: 5416016 (1995-05-01), Low et al.
patent: 5589332 (1996-12-01), Shih et al.
patent: 5627053 (1997-05-01), Usman et al.
patent: 5631359 (1997-05-01), Chowrira et al.
patent: 5631360 (1997-05-01), Usman et al.
patent: 5633133 (1997-05-01), Long et al.
patent: 5670633 (1997-09-01), Cook et al.
patent: 5672695 (1997-09-01), Eckstein et al.
patent: 5716824 (1998-02-01), Beigelman et al.
patent: 5741679 (1998-04-01), George et al.
patent: 5792847 (1998-08-01), Buhr et al.
patent: 5804683 (1998-09-01), Usman et al.
patent: 5814620 (1998-09-01), Robinson et al.
patent: 5831071 (1998-11-01), Usman et al.
patent: 5834186 (1998-11-01), George et al.
patent: 5849902 (1998-12-01), Arrow et al.
patent: 5871914 (1999-02-01), Nathan
patent: 5898031 (1999-04-01), Crooke
patent: 5989912 (1999-11-01), Arrow et al.
patent: 5998203 (1999-12-01), Adamic et al.
patent: 6001311 (1999-12-01), Brennan
patent: 6005087 (1999-12-01), Cook et al.
patent: 6008400 (1999-12-01), Scaringe et al.
patent: 6054576 (2000-04-01), Bellon et al.
patent: 6107094 (2000-08-01), Crooke
patent: 6111086 (2000-08-01), Scaringe et al.
patent: 6117657 (2000-09-01), Usman et al.
patent: 6153737 (2000-11-01), Manoharan et al.
patent: 6162909 (2000-12-01), Bellon et al.
patent: 6168778 (2001-01-01), Janjic et al.
patent: 6303773 (2001-10-01), Bellon et al.
patent: 6335434 (2002-01-01), Guzaev et al.
patent: 6353098 (2002-03-01), Usman et al.
patent: 6362323 (2002-03-01), Usman et al.
patent: 6395492 (2002-05-01), Manoharan et al.
patent: 6437117 (2002-08-01), Usman et al.
patent: 6469158 (2002-10-01), Usman et al.
patent: 6476205 (2002-11-01), Buhr et al.
patent: 6506559 (2003-01-01), Fire et al.
patent: 6528631 (2003-03-01), Cook et al.
patent: 2359180 (2000-08-01), None
patent: 0 360 257 (1990-02-01), None
patent: 88/09810 (1988-12-01), None
patent: 89/02439 (1989-03-01), None
patent: 90/12096 (1990-10-01), None
patent: 90/14090 (1990-11-01), None
patent: 91/03162 (1991-03-01), None
patent: 92/07065 (1992-04-01), None
patent: 93/15187 (1993-08-01), None
patent: 93/23569 (1993-11-01), None
patent: 94/01550 (1994-01-01), None
patent: 95/06731 (1995-03-01), None
patent: 95/11304 (1995-04-01), None
patent: 95/11910 (1995-05-01), None
patent: 96/10390 (1996-04-01), None
patent: 96/10391 (1996-04-01), None
patent: 96/10392 (1996-04-01), None
patent: 96/22689 (1996-08-01), None
patent: 97/26270 (1997-07-01), None
patent: 98/13526 (1998-04-01), None
patent: 98/27104 (1998-06-01), None
patent: 98/28317 (1998-07-01), None
patent: 98/43993 (1998-10-01), None
patent: 98/58058 (1998-12-01), None
patent: 99/07409 (1999-02-01), None
patent: 99/16871 (1999-04-01), None
patent: 99/17120 (1999-04-01), None
patent: 99/29842 (1999-06-01), None
patent: 99/32619 (1999-07-01), None
patent: 99/49029 (1999-09-01), None
patent: 99/53050 (1999-10-01), None
patent: 99/54459 (1999-10-01), None
patent: 99/55857 (1999-11-01), None
patent: 99/61631 (1999-12-01), None
patent: 99/66063 (1999-12-01), None
patent: 00/01846 (2000-01-01), None
patent: 00/24931 (2000-05-01), None
patent: 00/26226 (2000-05-01), None
patent: 00/44895 (2000-08-01), None
patent: 00/44914 (2000-08-01), None
patent: 00/49035 (2000-08-01), None
patent: 00/63364 (2000-10-01), None
patent: 01/29058 (2001-04-01), None
patent: 01/36646 (2001-05-01), None
patent: 01/96584 (2001-12-01), None
patent: 02/22636 (2002-03-01), None
patent: 02/15876 (2002-05-01), None
patent: 03/070918 (2003-08-01), None
patent: 03/074654 (2003-09-01), None
2006 Chemical Abstracts Service Catalog, published by Chemical Abstracts Service, p. 52.
U.S. Appl. No. 09/301,511, filed Apr. 28, 1999, Beigelman et al.
U.S. Appl. No. 09/800,594, filed Mar. 6, 2001, Usman et al.
U.S. Appl. No. 10/427,160, filed Apr. 30, 2003, Beigelman et al.
U.S. Appl. No. 60/082,404, filed Apr. 20, 1998, Thompson et al.
U.S. Appl. No. 60/292,217, filed May 18, 2001, Adamic et al.
U.S. Appl. No. 60/306,883, filed Jul. 20, 2001, Vargeese et al.
U.S. Appl. No. 60/311,865, filed Aug. 13, 2001, Vargeese et al.
U.S. Appl. No. 60/358,580, filed Feb. 20, 2002, Beigelman et al.
U.S. Appl. No. 60/362,016, filed Mar. 6, 2002, Matulic-Adamic et al.
U.S. Appl. No. 60/363,124, filed Mar. 11, 2002, Beigelman et al.
U.S. Appl. No. 60/386,782, filed Jun. 6, 2002, Beigelman et al.
U.S. Appl. No. 60/406,784, filed Aug. 29, 2002, Beigelman et al.
U.S. Appl. No. 60/408,378, filed Sep. 5, 2002 Beigelman et al.
U.S. Appl. No. 60/409,293, filed Sep. 9, 2002, Beigelman et al.
Abramovitz et al., “Catalytic Role of 2′-Hydroxyl Groups Within a Group II Intron Active Site,”Science271:1410-1413 (1996).
Allshire, “RNAi and Heterochromatin—A Hushed-up Affair,”Science297:1818-1819 (2002).
Antopolsky et al., “Peptide-Oligonucleotide Phosphorothioate Conjugates with Membrane Translocation and Nuclear Localization Properties,”Bioconjugate Chem. 10:598-606 (1999).
Arap et al., “Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model,”Science279:377-380 (1998).
Baenziger and Fiete, “Galactose and N-Acetylgalactosamine-Specific Endocytosis of Glycopeptides by Isolated Rat Hepatocytes,” Cell 22:611-620 (1980).
Bahramian et al., “Transcriptional and Posttranscriptional Silencing of Rodent α1(I) Collagen by a Homologous Transcriptionally Self-Silenced Transgene,” Molecular and Cellular Biology, 274-283 (1999).
Banerjee and Turner, “The Time Dependence of Chemical Modification Reveals Slow Steps in the Folding of a Group I Ribozyme,”Biochemistry34:6504-6512 (1995).
Bartel and Szostak, “Isolation of New Ribozymes from a Large Pool of Random Sequences,”Science261:1411-1418 (1993).
Bass, “The short answer,”Nature411:428-429 (2001).
Beaucage and Iyer, “The Functionalization of Oligonucleotides Via Phosphoramidite Derivatives,”Tetrahedron49:1925-1963 (1993).
Beaudry and Joyce, “Directed Evolution of an RNA Enzyme,”Science257:635-641 (1992).
Beigelman et al., “Chemical Modification of Hammerhead Ribozymes,”The Journal of Biological Chemistry270:25702-25708 (1995).
Bellon et al., “Amino-Linked Ribozymes: Post-Synthetic Conjugation of Half-Ribozymes,”Nucleosides&Nucleotides16:951-954 (1997).
Bellon et al., “Post-synthetically Ligated Ribozymes: An Alternative Approach to Iterative Solid Phase Synthesis,”Bioconjugate Chem. 8:204-212 (1997).
Berzal-Herranz et al., “Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme,”EBMO J. 12:2567-2574 (1993).
Berzal-Herranz et al., “In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed clevage and ligation reactions,”Genes&Development6:129-134 (1992).
Bevilacqua et al., “A Mechanistic Framework for the Second Step of Splicing Catalyzed by theTetrahymenaRibozyme,”Biochemistry35:648-568 (1996).
Bongartz et al., “Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide,”Nucleic Acids Research22:4681-4688 (1994).
Bonora et al.,“Biological Properties of Antisense Oligonucleotides Conjugated to Different High-Molecular Mass Poly(ethylen glycols),”Nucleosides&Nucleotides18:1723-1725 (1999).
Bonora et al., “Synthesis and Characterization of High-Molecular Mass Polyethylene Glycol-Conjugated Oligonucleotide
Chen Tongqian
Haeberli Peter
Vargeese Chandra
Wang Weimin
Jiang Shaojia Anna
Olson Eric S
Sirna Therapeutics, Inc.
LandOfFree
Conjugates and compositions for cellular delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates and compositions for cellular delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates and compositions for cellular delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4076190